Équipe
SALVATORE VALITUTTI

DynAct :

Dynamique moléculaire des interactions lymphocytaires

 

L’équipe fait partie du consortium « ATTACK Cancer  » financé par un ERC Synergy Grant, visant à mettre au point des traitements anticancéreux plus efficaces et plus ciblés.

Le laboratoire d’Excellence Toulouse Cancer est un projet qui vise à comprendre les mécanismes de résistance et de rechute dans les cancers.

Les spécificités
de notre axe de recherche

Les réponses immunitaires sont basées sur des interactions multiples et dynamiques entre les cellules du système immunitaire conduisant à la formation de zones de signalisation spécialisées, les synapses immunologiques.

Notre équipe applique une combinaison d’approches de pointe, incluant l’imagerie des cellules vivantes rapide et la microscopie de super-résolution (sur des cellules isolées et des tranches de tissus humains) mais également la modélisation mathématique, de manière à visualiser et interpréter les dynamiques moléculaires se produisant au niveau des synapses immunologiques. Décrypter la communication intercellulaire au niveau des synapses immunologiques peut contribuer à concevoir des stratégies thérapeutiques innovantes visant à moduler les réponses immunitaires dans différents contextes pathologiques.

Synapse immunologique

  Lymphocytes T cytotoxiques

Immunologie tumorale
Techniques d’imagerie en temps réel

Immuno-évasion tumorale

Pyroptose

Biologie computationnelle

Modélisation in silico
Vision par ordinateur

Programmation génétique cartésienne

T CD8+ mémoire-résidents

     Microenvironement tumoral

DES PROJETS
DE RECHERCHE

LES FOCUS
DE L’ÉQUIPE

PRODUCTIONS SCIENTIFIQUES

PUBLICATIONS 2025
7813506 UNNZZUAJ 2025 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22YFTXYPU6%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leveque%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLeveque%2C%20Edouard%2C%20R%26%23xE9%3Bgis%20Joulia%2C%20Louise%20Battut%2C%20Camille%20Laurent%2C%20Salvatore%20Valitutti%2C%20Nicolas%20C%26%23xE9%3Bnac%2C%20Gilles%20Dietrich%2C%20and%20Eric%20Espinosa.%20%26%23x201C%3BMast%20Cells%20Promote%20Inflammatory%20Th17%20Cells%20and%20Impair%20Treg%20Cells%20Through%20an%20IL-1%26%23x3B2%3B%20and%20PGE2%20Axis.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Inflammation%20Research%26lt%3B%5C%2Fi%26gt%3B%2018%20%282025%29%3A%205851%26%23x2013%3B65.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FJIR.S509931%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FJIR.S509931%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mast%20Cells%20Promote%20Inflammatory%20Th17%20Cells%20and%20Impair%20Treg%20Cells%20Through%20an%20IL-1%5Cu03b2%20and%20PGE2%20Axis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Leveque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9gis%22%2C%22lastName%22%3A%22Joulia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%22%2C%22lastName%22%3A%22Battut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Laurent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22C%5Cu00e9nac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Dietrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Espinosa%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20CD4%2B%20effector%20T%20cells%20%28Teffs%29%20play%20a%20key%20role%20in%20immune%20responses%20by%20infiltrating%20the%20sites%20of%20inflammation%20and%20modulating%20local%20leukocyte%20activity.%20In%20turn%20resident%20immune%20cells%20shape%20their%20response.%20This%20study%20aimed%20to%20investigate%20the%20influence%20of%20mast%20cells%20%28MCs%29%20on%20Teff%20biological%20responses.%5CnMETHODS%3A%20This%20study%20examined%20human%20MC-Teff%20interactions%2C%20focusing%20on%20how%20MCs%20shape%20Teff%20responses.%20Flow%20cytometry%2C%20qRT-PCR%2C%20and%20cytokine%20assays%20were%20used%20to%20analyze%20the%20impact%20of%20primary%20human%20MCs%20on%20the%20Teff%20phenotype%20and%20function.%20MC-Teff%20crosstalk%20within%20Crohn%26%23039%3Bs%20disease%20patient%20tissues%20was%20assessed%20using%20confocal%20microscopy%20and%20advanced%20image%20analysis.%5CnRESULTS%3A%20MCs%20promoted%20the%20differentiation%20of%20Th17%20cells%2C%20particularly%20the%20inflammatory%20Th17.1%20subset%2C%20that%20secretes%20IFN-%5Cu03b3%20and%20GM-CSF.%20This%20differentiation%20was%20driven%20by%20the%20PGE2%20and%20IL-1%5Cu03b2%20axis.%20Additionally%2C%20MCs%20disrupted%20the%20phenotype%20and%20impaired%20the%20suppressive%20function%20of%20regulatory%20T%20cells%20%28Tregs%29%20through%20PGE2%2C%20skewing%20the%20Th17%5C%2FTreg%20balance.%20The%20analysis%20of%20biopsies%20from%20patients%20with%20Crohn%26%23039%3Bs%20disease%20indicated%20that%20this%20MC%5C%2FTeff%20crosstalk%20may%20play%20a%20role%20in%20the%20pathogenesis%20of%20auto-inflammatory%20processes.%5CnCONCLUSION%3A%20MCs%20influence%20CD4%2B%20T%20cell%20responses%20by%20fostering%20pro-inflammatory%20Th17%20differentiation%20while%20impairing%20Treg%20function.%20This%20interaction%20underpins%20a%20Th17%5C%2FTreg%20imbalance%2C%20which%20is%20significant%20in%20auto-inflammatory%20diseases%20such%20as%20Crohn%26%23039%3Bs%20disease%2C%20positioning%20MCs%20as%20critical%20drivers%20of%20disease%20pathogenesis.%22%2C%22date%22%3A%222025%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FJIR.S509931%22%2C%22ISSN%22%3A%221178-7031%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222025-11-11T18%3A51%3A55Z%22%7D%7D%5D%7D
Leveque, Edouard, Régis Joulia, Louise Battut, Camille Laurent, Salvatore Valitutti, Nicolas Cénac, Gilles Dietrich, and Eric Espinosa. “Mast Cells Promote Inflammatory Th17 Cells and Impair Treg Cells Through an IL-1β and PGE2 Axis.” Journal of Inflammation Research 18 (2025): 5851–65. https://doi.org/10.2147/JIR.S509931.
PUBLICATIONS 2024
7813506 UNNZZUAJ 2024 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IJHYKED5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zevolini%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZevolini%2C%20Fabrizia%2C%20Anna%20Onnis%2C%20Roxana%20Khazen%2C%20Sabina%20M%26%23xFC%3Bller%2C%20Giuseppe%20Marotta%2C%20Salvatore%20Valitutti%2C%20Francesca%20Finetti%2C%20and%20Cosima%20T.%20Baldari.%20%26%23x201C%3BPolo-like%20Kinase%201%20Regulates%20Immune%20Synapse%20Assembly%20and%20Cytotoxic%20T%20Cell%20Function%20by%20Driving%20Microtubule%20Dynamics.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Cell%20Science%26lt%3B%5C%2Fi%26gt%3B%20137%2C%20no.%205%20%28March%201%2C%202024%29%3A%20jcs261476.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1242%5C%2Fjcs.261476%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1242%5C%2Fjcs.261476%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polo-like%20kinase%201%20regulates%20immune%20synapse%20assembly%20and%20cytotoxic%20T%20cell%20function%20by%20driving%20microtubule%20dynamics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrizia%22%2C%22lastName%22%3A%22Zevolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Onnis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Marotta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Finetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cosima%20T.%22%2C%22lastName%22%3A%22Baldari%22%7D%5D%2C%22abstractNote%22%3A%22Elimination%20of%20virally%20infected%20or%20tumoral%20cells%20is%20mediated%20by%20cytotoxic%20T%20cells%20%28CTL%29.%20Upon%20antigen%20recognition%2C%20CTLs%20assemble%20a%20specialized%20signaling%20and%20secretory%20domain%20at%20the%20interface%20with%20their%20target%2C%20the%20immune%20synapse%20%28IS%29.%20During%20IS%20formation%2C%20CTLs%20acquire%20a%20transient%20polarity%2C%20marked%20by%20re-orientation%20of%20the%20centrosome%20and%20microtubule%20cytoskeleton%20toward%20the%20IS%2C%20thus%20directing%20the%20transport%20and%20delivery%20of%20the%20lytic%20granules%20to%20the%20target%20cell.%20Based%20on%20the%20implication%20that%20the%20kinase%20Aurora%20A%20has%20a%20role%20in%20CTL%20function%2C%20we%20hypothesized%20that%20its%20substrate%2C%20the%20mitotic%20regulator%20Polo-like%20kinase%201%20%28PLK1%29%2C%20might%20participate%20in%20CTL%20IS%20assembly.%20We%20demonstrate%20that%20PLK1%20is%20phosphorylated%20upon%20TCR%20triggering%20and%20polarizes%20to%20the%20IS.%20PLK1%20silencing%20or%20inhibition%20results%20in%20impaired%20IS%20assembly%20and%20function%2C%20as%20witnessed%20by%20defective%20synaptic%20accumulation%20of%20T%20cell%20receptors%20%28TCRs%29%2C%20as%20well%20as%20compromised%20centrosome%20and%20lytic%20granule%20polarization%20to%20the%20IS%2C%20resulting%20in%20impaired%20target%20cell%20killing.%20This%20function%20is%20achieved%20by%20coupling%20early%20signaling%20to%20microtubule%20dynamics%2C%20a%20function%20pivotal%20for%20CTL-mediated%20cytotoxicity.%20These%20results%20identify%20PLK1%20as%20a%20new%20player%20in%20CTL%20IS%20assembly%20and%20function.%22%2C%22date%22%3A%222024-03-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1242%5C%2Fjcs.261476%22%2C%22ISSN%22%3A%221477-9137%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222024-01-22T08%3A38%3A12Z%22%7D%7D%2C%7B%22key%22%3A%229QSJPS7F%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Battut%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBattut%2C%20Louise%2C%20Edouard%20Leveque%2C%20Salvatore%20Valitutti%2C%20Nicolas%20Cenac%2C%20Gilles%20Dietrich%2C%20and%20Eric%20Espinosa.%20%26%23x201C%3BIL-33-Primed%20Human%20Mast%20Cells%20Drive%20IL-9%20Production%20by%20CD4%2B%20Effector%20T%20Cells%20in%20an%20OX40L-Dependent%20Manner.%26%23x201D%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2015%20%282024%29%3A%201470546.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1470546%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2024.1470546%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22IL-33-primed%20human%20mast%20cells%20drive%20IL-9%20production%20by%20CD4%2B%20effector%20T%20cells%20in%20an%20OX40L-dependent%20manner%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%22%2C%22lastName%22%3A%22Battut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Leveque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Cenac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Dietrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Espinosa%22%7D%5D%2C%22abstractNote%22%3A%22Interleukin-33%20%28IL-33%29%20is%20an%20alarmin%20released%20by%20epithelial%20cells%20in%20response%20to%20tissue%20damage.%20It%20activates%20resident%20immune%20sentinel%20cells%2C%20which%20then%20produce%20signals%20commonly%20associated%20with%20type%202%20immune%20responses%2C%20particularly%20affecting%20infiltrating%20antigen-specific%20T%20cells.%20Given%20that%20mast%20cells%20%28MCs%29%20are%20a%20primary%20target%20of%20IL-33%20and%20can%20shape%20T%20helper%20%28Th%29%20cell%20responses%2C%20we%20investigated%20the%20effect%20of%20IL-33%20priming%20on%20the%20ability%20of%20MCs%20to%20influence%20Th%20cell%20cytokine%20production.%20To%20examine%20the%20Th%20cell%5C%2FMC%20interaction%2C%20we%20developed%20human%20primary%20MC%5C%2Fmemory%20CD4%2B%20T-cell%20coculture%20systems%20involving%20both%20cognate%20and%20non-cognate%20interactions.%20Our%20results%20demonstrated%20that%20IL-33-primed%20MCs%2C%20whether%20as%20bystander%20cells%20cocultured%20with%20activated%20effector%20T%20cells%20or%20functioning%20as%20antigen-presenting%20cells%2C%20promoted%20IL-9%20and%20increased%20IL-13%20production%20in%20Th%20cells%20via%20an%20OX40L-dependent%20mechanism.%20This%20indicates%20that%20MCs%20sense%20IL-33-associated%20danger%2C%20prompting%20them%20to%20direct%20Th%20cells%20to%20produce%20the%20key%20type%202%20effector%20cytokines%20IL-9%20and%20IL-13.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2024.1470546%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222024-10-28T13%3A20%3A02Z%22%7D%7D%5D%7D
Zevolini, Fabrizia, Anna Onnis, Roxana Khazen, Sabina Müller, Giuseppe Marotta, Salvatore Valitutti, Francesca Finetti, and Cosima T. Baldari. “Polo-like Kinase 1 Regulates Immune Synapse Assembly and Cytotoxic T Cell Function by Driving Microtubule Dynamics.” Journal of Cell Science 137, no. 5 (March 1, 2024): jcs261476. https://doi.org/10.1242/jcs.261476.
Battut, Louise, Edouard Leveque, Salvatore Valitutti, Nicolas Cenac, Gilles Dietrich, and Eric Espinosa. “IL-33-Primed Human Mast Cells Drive IL-9 Production by CD4+ Effector T Cells in an OX40L-Dependent Manner.” Frontiers in Immunology 15 (2024): 1470546. https://doi.org/10.3389/fimmu.2024.1470546.
PUBLICATIONS 2023
7813506 UNNZZUAJ 2023 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228XW8LQVI%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Baldari%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBaldari%2C%20Cosima%20T.%2C%20Salvatore%20Valitutti%2C%20and%20Michael%20L.%20Dustin.%20%26%23x201C%3BEditorial%3A%20Mechanisms%20of%20Lymphocyte%20Mediated%20Cytotoxicity%20in%20Health%20and%20Disease.%26%23x201D%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2014%20%282023%29%3A%201226870.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2023.1226870%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2023.1226870%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Editorial%3A%20Mechanisms%20of%20lymphocyte%20mediated%20cytotoxicity%20in%20health%20and%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cosima%20T.%22%2C%22lastName%22%3A%22Baldari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Dustin%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2023.1226870%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-06-19T14%3A39%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22MJGZMWI4%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22M%5Cu00fcller%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BM%26%23xFC%3Bller%2C%20Sabina%2C%20Liza%20Filali%2C%20Marie-Pierre%20Puissegur%2C%20and%20Salvatore%20Valitutti.%20%26%23x201C%3BMeasuring%20CTL%20Lytic%20Granule%20Secretion%20and%20Target%20Cell%20Membrane%20Repair%20by%20Fluorescent%20Lipophilic%20Dye%20Uptake%20at%20the%20Lytic%20Synapse.%26%23x201D%3B%20%26lt%3Bi%26gt%3BMethods%20in%20Molecular%20Biology%20%28Clifton%2C%20N.J.%29%26lt%3B%5C%2Fi%26gt%3B%202654%20%282023%29%3A%20463%26%23x2013%3B76.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-1-0716-3135-5_30%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-1-0716-3135-5_30%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Measuring%20CTL%20Lytic%20Granule%20Secretion%20and%20Target%20Cell%20Membrane%20Repair%20by%20Fluorescent%20Lipophilic%20Dye%20Uptake%20at%20the%20Lytic%20Synapse%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liza%22%2C%22lastName%22%3A%22Filali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Pierre%22%2C%22lastName%22%3A%22Puissegur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22CD8%2B%20cytotoxic%20T%20lymphocytes%20%28CTL%29%20play%20a%20key%20role%20in%20anti-tumor%20immune%20response.%20They%20are%20therefore%20at%20the%20heart%20of%20current%20immunotherapy%20protocols%20against%20cancer.%20Despite%20current%20strategies%20to%20potentiate%20CTL%20responses%2C%20cancer%20cells%20can%20resist%20CTL%20attack%2C%20thus%20limiting%20the%20efficacy%20of%20immunotherapies.%20To%20optimize%20immunotherapy%2C%20it%20is%20urgent%20to%20develop%20rapid%20assays%20allowing%20to%20assess%20CTL-cancer%20cell%20confrontation%20at%20the%20lytic%20synapse.In%20this%20chapter%2C%20we%20describe%20a%20flow%20cytometry-based%20method%20to%20simultaneously%20assess%20the%20extent%20of%20CTL%20activation%20and%20of%20tumor%20cell%20reparative%20membrane%20turnover%20in%20CTL%5C%2Ftarget%20cell%20conjugates.%20Such%20a%20method%20can%20be%20performed%20using%20a%20limited%20number%20of%20cells.%20It%20can%20therefore%20be%20employed%20in%20clinical%20settings%20when%20only%20a%20few%20patient-derived%20cells%20might%20be%20available.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2F978-1-0716-3135-5_30%22%2C%22ISSN%22%3A%221940-6029%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-05-02T08%3A26%3A25Z%22%7D%7D%5D%7D
Baldari, Cosima T., Salvatore Valitutti, and Michael L. Dustin. “Editorial: Mechanisms of Lymphocyte Mediated Cytotoxicity in Health and Disease.” Frontiers in Immunology 14 (2023): 1226870. https://doi.org/10.3389/fimmu.2023.1226870.
Müller, Sabina, Liza Filali, Marie-Pierre Puissegur, and Salvatore Valitutti. “Measuring CTL Lytic Granule Secretion and Target Cell Membrane Repair by Fluorescent Lipophilic Dye Uptake at the Lytic Synapse.” Methods in Molecular Biology (Clifton, N.J.) 2654 (2023): 463–76. https://doi.org/10.1007/978-1-0716-3135-5_30.
PUBLICATIONS 2022
7813506 UNNZZUAJ 2022 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Z6UQN6PS%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22McKenzie%20and%20Valitutti%22%2C%22parsedDate%22%3A%222022-12-31%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMcKenzie%2C%20Brienne%2C%20and%20Salvatore%20Valitutti.%20%26%23x201C%3BResisting%20T%20Cell%20Attack%3A%20Tumor-Cell-Intrinsic%20Defense%20and%20Reparation%20Mechanisms.%26%23x201D%3B%20%26lt%3Bi%26gt%3BTrends%20in%20Cancer%26lt%3B%5C%2Fi%26gt%3B%2C%20December%2031%2C%202022%2C%20S2405-8033%2822%2900264-3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.trecan.2022.12.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.trecan.2022.12.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Resisting%20T%20cell%20attack%3A%20tumor-cell-intrinsic%20defense%20and%20reparation%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brienne%22%2C%22lastName%22%3A%22McKenzie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22Cytotoxic%20T%20lymphocytes%20%28CTLs%29%20are%20antigen-specific%20killer%20cells%20equipped%20to%20identify%20and%20eliminate%20host%20cells%20that%20have%20been%20altered%20through%20infection%20or%20transformation.%20Both%20chimeric%20antigen-receptor%20%28CAR%29%20T%20cell%20therapies%20and%20immune%20checkpoint%20blockade%20%28ICB%29%20therapies%20are%20based%20on%20successful%20elimination%20of%20tumor%20cells%20by%20cytotoxic%20effectors.%20In%20this%20opinion%20article%2C%20we%20outline%20cell-intrinsic%20mechanisms%20by%20which%20tumor%20cells%20defend%20against%20CTLs%2C%20highlighting%20pathways%20that%20confer%20resistance%20and%20proposing%20opportunities%20for%20combination%20therapies.%20We%20discuss%20how%20exogenous%20killing%20entities%20%5Be.g.%2C%20supramolecular%20attack%20particles%20%28SMAPs%29%5D%20offer%20a%20novel%20strategy%20to%20circumvent%20cellular%20resistance%20mechanisms.%20Our%20opinion%20article%20highlights%20the%20importance%20of%20identifying%2C%20quantifying%2C%20and%20targeting%20tumor%20defense%20mechanisms%20at%20the%20interface%20between%20tumor%20cells%20and%20CTLs%20as%20a%20critical%20consideration%20in%20the%20development%20of%20immunotherapy%20approaches.%22%2C%22date%22%3A%222022-12-31%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.trecan.2022.12.003%22%2C%22ISSN%22%3A%222405-8025%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-01-03T14%3A18%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22J6ELAH2Z%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Puissant-Lubrano%20et%20al.%22%2C%22parsedDate%22%3A%222022-12-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPuissant-Lubrano%2C%20B%26%23xE9%3Bn%26%23xE9%3Bdicte%2C%20Charl%26%23xE8%3Bne%20Bouthemy%2C%20Nicolas%20Congy-Jolivet%2C%20Jean%20Milhes%2C%20Vincent%20Minville%2C%20Nassim%20Kamar%2C%20Le%26%23xEF%3Bla%20Demini%2C%20Franck%20Zal%2C%20and%20Yves%20Renaudineau.%20%26%23x201C%3BThe%20Oxygen%20Carrier%20M101%20Alleviates%20Complement%20Activation%2C%20Which%20May%20Be%20Beneficial%20for%20Donor%20Organ%20Preservation.%26%23x201D%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2013%20%28December%209%2C%202022%29%3A%201006761.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.1006761%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.1006761%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20oxygen%20carrier%20M101%20alleviates%20complement%20activation%2C%20which%20may%20be%20beneficial%20for%20donor%20organ%20preservation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9n%5Cu00e9dicte%22%2C%22lastName%22%3A%22Puissant-Lubrano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charl%5Cu00e8ne%22%2C%22lastName%22%3A%22Bouthemy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Congy-Jolivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Milhes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Minville%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nassim%22%2C%22lastName%22%3A%22Kamar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Le%5Cu00efla%22%2C%22lastName%22%3A%22Demini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Zal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Renaudineau%22%7D%5D%2C%22abstractNote%22%3A%22During%20organ%20transplantation%2C%20ischemia%5C%2Freperfusion%20injury%20and%20pre-formed%20anti-HLA%20antibodies%20are%20the%20main%20cause%20of%20delayed%20graft%20function%20and%20recovery%20through%20the%20activation%20of%20the%20complement%20system.%20By%20supplying%20oxygen%20during%20transplantation%2C%20M101%20is%20suspected%20to%20avoid%20complement%20activation%2C%20however%2C%20a%20direct%20effect%20exerted%20by%20M101%20on%20this%20pathway%20is%20unknown.%20This%20was%20tested%20by%20using%20functional%20assays%20%28lymphocytotoxic%20crossmatch%20test%2C%20C3d%20Luminex-based%20assay%2C%2050%25%20complement%20hemolysis%20%5BCH50%5D%2C%20and%2050%25%20alternative%20complement%20pathway%20%5BAP50%5C%2FAH50%5D%29%2C%20and%20quantitative%20assays%20%28C3%2C%20C3a%2C%20C4%2C%20C5%2C%20C5a%2C%20C6%2C%20C7%2C%20C8%2C%20C9%20and%20sC5b-9%29.%20M101%20interferes%20with%20the%20anti-HLA%20lymphocytotoxic%20crossmatch%20assay%2C%20and%20this%20effect%20is%20complement-dependent%20as%20M101%20inhibits%20the%20classical%20complement%20pathway%20%28CH50%29%20in%20a%20dose-dependent%20and%20stable%20manner.%20Such%20inhibition%20was%20independent%20from%20a%20proteolytic%20effect%20%28fractions%20C3%20to%20C9%29%20but%20related%20to%20a%20dose-dependent%20inhibition%20of%20the%20C3%20convertase%20as%20demonstrated%20by%20exploring%20downstream%20the%20release%20of%20the%20anaphylatoxins%20%28C3a%20and%20C5a%29%2C%20C3d%2C%20and%20sC5b-9.%20The%20C3%20convertase%20inhibition%20in%20the%20presence%20of%20M101%20was%20further%20demonstrated%20in%20the%20AP50%5C%2FAH50%20assay.%20In%20conclusion%2C%20the%20use%20of%20M101%20avoids%20the%20activation%20of%20the%20complement%20pathway%2C%20which%20constitutes%20an%20additional%20advantage%20for%20this%20extracellular%20hemoglobin%20to%20preserve%20grafts%20from%20ischemia%5C%2Freperfusion%20injury%20and%20preformed%20anti-HLA%20antibodies.%22%2C%22date%22%3A%2212-09-2022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.1006761%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-01-03T10%3A10%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22Z39AN5YN%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cassioli%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCassioli%2C%20Chiara%2C%20Laura%20Patrussi%2C%20Salvatore%20Valitutti%2C%20and%20Cosima%20T.%20Baldari.%20%26%23x201C%3BLearning%20from%20TCR%20Signaling%20and%20Immunological%20Synapse%20Assembly%20to%20Build%20New%20Chimeric%20Antigen%20Receptors%20%28CARs%29.%26%23x201D%3B%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Molecular%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2023%2C%20no.%2022%20%28November%2017%2C%202022%29%3A%2014255.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms232214255%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms232214255%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Learning%20from%20TCR%20Signaling%20and%20Immunological%20Synapse%20Assembly%20to%20Build%20New%20Chimeric%20Antigen%20Receptors%20%28CARs%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Cassioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Patrussi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cosima%20T.%22%2C%22lastName%22%3A%22Baldari%22%7D%5D%2C%22abstractNote%22%3A%22Chimeric%20antigen%20receptor%20%28CAR%29%20T%20cell%20immunotherapy%20is%20a%20revolutionary%20pillar%20in%20cancer%20treatment.%20Clinical%20experience%20has%20shown%20remarkable%20successes%20in%20the%20treatment%20of%20certain%20hematological%20malignancies%20but%20only%20limited%20efficacy%20against%20B%20cell%20chronic%20lymphocytic%20leukemia%20%28CLL%29%20and%20other%20cancer%20types%2C%20especially%20solid%20tumors.%20A%20wide%20range%20of%20engineering%20strategies%20have%20been%20employed%20to%20overcome%20the%20limitations%20of%20CAR%20T%20cell%20therapy.%20However%2C%20it%20has%20become%20increasingly%20clear%20that%20CARs%20have%20unique%2C%20unexpected%20features%3B%20hence%2C%20a%20deep%20understanding%20of%20how%20CARs%20signal%20and%20trigger%20the%20formation%20of%20a%20non-conventional%20immunological%20synapse%20%28IS%29%2C%20the%20signaling%20platform%20required%20for%20T%20cell%20activation%20and%20execution%20of%20effector%20functions%2C%20would%20lead%20a%20shift%20from%20empirical%20testing%20to%20the%20rational%20design%20of%20new%20CAR%20constructs.%20Here%2C%20we%20review%20current%20knowledge%20of%20CARs%2C%20focusing%20on%20their%20structure%2C%20signaling%20and%20role%20in%20CAR%20T%20cell%20IS%20assembly.%20We%2C%20moreover%2C%20discuss%20the%20molecular%20features%20accounting%20for%20poor%20responses%20in%20CLL%20patients%20treated%20with%20anti-CD19%20CAR%20T%20cells%20and%20propose%20CLL%20as%20a%20paradigm%20for%20diseases%20connected%20to%20IS%20dysfunctions%20that%20could%20significantly%20benefit%20from%20the%20development%20of%20novel%20CARs%20to%20generate%20a%20productive%20anti-tumor%20response.%22%2C%22date%22%3A%222022-11-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms232214255%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222022-11-30T14%3A00%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22AFJPG495%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leveque%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-09%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLeveque%2C%20Edouard%2C%20Axel%20Rouch%2C%20Charlotte%20Syrykh%2C%20Julien%20Mazi%26%23xE8%3Bres%2C%20Laurent%20Brouchet%2C%20Salvatore%20Valitutti%2C%20Eric%20Espinosa%2C%20and%20Fanny%20Lafouresse.%20%26%23x201C%3BPhenotypic%20and%20Histological%20Distribution%20Analysis%20Identify%20Mast%20Cell%20Heterogeneity%20in%20Non-Small%20Cell%20Lung%20Cancer.%26%23x201D%3B%20%26lt%3Bi%26gt%3BCancers%26lt%3B%5C%2Fi%26gt%3B%2014%2C%20no.%206%20%28March%209%2C%202022%29%3A%201394.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers14061394%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers14061394%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phenotypic%20and%20Histological%20Distribution%20Analysis%20Identify%20Mast%20Cell%20Heterogeneity%20in%20Non-Small%20Cell%20Lung%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Leveque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Rouch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Syrykh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Mazi%5Cu00e8res%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Brouchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Espinosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lafouresse%22%7D%5D%2C%22abstractNote%22%3A%22Mast%20cells%20%28MCs%29%20are%20multifaceted%20innate%20immune%20cells%20often%20present%20in%20the%20tumor%20microenvironment%20%28TME%29.%20However%2C%20MCs%20have%20been%20only%20barely%20characterized%20in%20studies%20focusing%20on%20global%20immune%20infiltrate%20phenotyping.%20Consequently%2C%20their%20role%20in%20cancer%20is%20still%20poorly%20understood.%20Furthermore%2C%20their%20prognosis%20value%20is%20confusing%20since%20MCs%20have%20been%20associated%20with%20good%20and%20bad%20%28or%20both%29%20prognosis%20depending%20on%20the%20cancer%20type.%20In%20this%20pilot%20study%20performed%20on%20a%20surgical%20cohort%20of%2048%20patients%20with%20Non-Small%20Cell%20Lung%20Cancer%20%28NSCLC%29%2C%20we%20characterized%20MC%20population%20within%20the%20TME%20and%20in%20matching%20non-lesional%20lung%20areas%2C%20by%20multicolor%20flow%20cytometry%20and%20confocal%20microscopy.%20Our%20results%20showed%20that%20tumor-associated%20MCs%20%28TAMCs%29%20harbor%20a%20distinct%20phenotype%20as%20compared%20with%20MCs%20present%20in%20non-lesional%20counterpart%20of%20the%20lung.%20Moreover%2C%20we%20found%20two%20TAMCs%20subsets%20based%20on%20the%20expression%20of%20CD103%20%28also%20named%20alphaE%20integrin%29.%20CD103%2B%20TAMCs%20appeared%20more%20mature%2C%20more%20prone%20to%20interact%20with%20CD4%2B%20T%20cells%2C%20and%20located%20closer%20to%20cancer%20cells%20than%20their%20CD103-%20counterpart.%20In%20spite%20of%20these%20characteristics%2C%20we%20did%20not%20observe%20a%20prognosis%20advantage%20of%20a%20high%20frequency%20of%20CD103%2B%20TAMCs%2C%20while%20a%20high%20frequency%20of%20total%20TAMC%20correlated%20with%20better%20overall%20survival%20and%20progression%20free%20survival.%20Together%2C%20this%20study%20reveals%20that%20TAMCs%20constitute%20a%20heterogeneous%20population%20and%20indicates%20that%20MC%20subsets%20should%20be%20considered%20for%20patients%26%23039%3B%20stratification%20and%20management%20in%20future%20research.%22%2C%22date%22%3A%222022-03-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers14061394%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222022-10-04T08%3A11%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22X5EWNQNM%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Filali%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-18%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFilali%2C%20Liza%2C%20Marie-Pierre%20Puissegur%2C%20Kevin%20Cortacero%2C%20Sylvain%20Cussat-Blanc%2C%20Roxana%20Khazen%2C%20Nathalie%20Van%20Acker%2C%20Fran%26%23xE7%3Bois-Xavier%20Frenois%2C%20et%20al.%20%26%23x201C%3BUltrarapid%20Lytic%20Granule%20Release%20from%20CTLs%20Activates%20Ca2%2B-Dependent%20Synaptic%20Resistance%20Pathways%20in%20Melanoma%20Cells.%26%23x201D%3B%20%26lt%3Bi%26gt%3BScience%20Advances%26lt%3B%5C%2Fi%26gt%3B%208%2C%20no.%207%20%28February%2018%2C%202022%29%3A%20eabk3234.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.abk3234%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.abk3234%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ultrarapid%20lytic%20granule%20release%20from%20CTLs%20activates%20Ca2%2B-dependent%20synaptic%20resistance%20pathways%20in%20melanoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liza%22%2C%22lastName%22%3A%22Filali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Pierre%22%2C%22lastName%22%3A%22Puissegur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Cortacero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Cussat-Blanc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Van%20Acker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois-Xavier%22%2C%22lastName%22%3A%22Frenois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Abreu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Vergier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brienne%22%2C%22lastName%22%3A%22McKenzie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22Human%20cytotoxic%20T%20lymphocytes%20%28CTLs%29%20exhibit%20ultrarapid%20lytic%20granule%20secretion%2C%20but%20whether%20melanoma%20cells%20mobilize%20defense%20mechanisms%20with%20commensurate%20rapidity%20remains%20unknown.%20We%20used%20single-cell%20time-lapse%20microscopy%20to%20offer%20high%20spatiotemporal%20resolution%20analyses%20of%20subcellular%20events%20in%20melanoma%20cells%20upon%20CTL%20attack.%20Target%20cell%20perforation%20initiated%20an%20intracellular%20Ca2%2B%20wave%20that%20propagated%20outward%20from%20the%20synapse%20within%20milliseconds%20and%20triggered%20lysosomal%20mobilization%20to%20the%20synapse%2C%20facilitating%20membrane%20repair%20and%20conferring%20resistance%20to%20CTL%20induced%20cytotoxicity.%20Inhibition%20of%20Ca2%2B%20flux%20and%20silencing%20of%20synaptotagmin%20VII%20limited%20synaptic%20lysosomal%20exposure%20and%20enhanced%20cytotoxicity.%20Multiplexed%20immunohistochemistry%20of%20patient%20melanoma%20nodules%20combined%20with%20automated%20image%20analysis%20showed%20that%20melanoma%20cells%20facing%20CD8%2B%20CTLs%20in%20the%20tumor%20periphery%20or%20peritumoral%20area%20exhibited%20significant%20lysosomal%20enrichment.%20Our%20results%20identified%20synaptic%20Ca2%2B%20entry%20as%20the%20definitive%20trigger%20for%20lysosomal%20deployment%20to%20the%20synapse%20upon%20CTL%20attack%20and%20highlighted%20an%20unpredicted%20defensive%20topology%20of%20lysosome%20distribution%20in%20melanoma%20nodules.%22%2C%22date%22%3A%222022-02-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.abk3234%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%2C%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A19%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22GB36CDQM%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Renaudineau%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRenaudineau%2C%20Yves%2C%20Laurent%20Sailler%2C%20Florence%20Abravanel%2C%20Jacques%20Izopet%2C%20Adrien%20Delourme%2C%20Damien%20Biotti%2C%20Jonathan%20Ciron%2C%20et%20al.%20%26%23x201C%3BGlucocorticoid%20Use%20as%20a%20Cause%20of%20Non-Cellular%20Immune%20Response%20to%20SARS-Cov2%20Spike%20in%20Patients%20with%20Immune%20System%20Diseases.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Autoimmunity%26lt%3B%5C%2Fi%26gt%3B%20133%20%282022%29%3A%20102912.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaut.2022.102912%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaut.2022.102912%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Glucocorticoid%20use%20as%20a%20cause%20of%20non-cellular%20immune%20response%20to%20SARS-Cov2%20Spike%20in%20patients%20with%20immune%20system%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Renaudineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Sailler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Abravanel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Izopet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Delourme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%22%2C%22lastName%22%3A%22Biotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ciron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Treiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Congy-Jolivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Bost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Blancher%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaut.2022.102912%22%2C%22ISSN%22%3A%2208968411%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0896841122001202%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222022-09-19T10%3A44%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22XQJZHVV3%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22McKenzie%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMcKenzie%2C%20Brienne%2C%20Roxana%20Khazen%2C%20and%20Salvatore%20Valitutti.%20%26%23x201C%3BGreek%20Fire%2C%20Poison%20Arrows%2C%20and%20Scorpion%20Bombs%3A%20How%20Tumor%20Cells%20Defend%20Against%20the%20Siege%20Weapons%20of%20Cytotoxic%20T%20Lymphocytes.%26%23x201D%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2013%20%282022%29%3A%20894306.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.894306%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2022.894306%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Greek%20Fire%2C%20Poison%20Arrows%2C%20and%20Scorpion%20Bombs%3A%20How%20Tumor%20Cells%20Defend%20Against%20the%20Siege%20Weapons%20of%20Cytotoxic%20T%20Lymphocytes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brienne%22%2C%22lastName%22%3A%22McKenzie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22CD8%2B%20cytotoxic%20T%20lymphocytes%20%28CTLs%29%20are%20the%20main%20cellular%20effectors%20of%20the%20adaptive%20immune%20response%20against%20cancer%20cells%2C%20which%20in%20turn%20have%20evolved%20sophisticated%20cellular%20defense%20mechanisms%20to%20withstand%20CTL%20attack.%20Herein%20we%20provide%20a%20critical%20review%20of%20the%20pertinent%20literature%20on%20early%20and%20late%20attack%5C%2Fdefense%20events%20taking%20place%20at%20the%20CTL%5C%2Ftarget%20cell%20lytic%20synapse.%20We%20examine%20the%20earliest%20steps%20of%20CTL-mediated%20cytotoxicity%20%28%26quot%3Bthe%20poison%20arrows%26quot%3B%29%20elicited%20within%20seconds%20of%20CTL%5C%2Ftarget%20cell%20encounter%2C%20which%20face%20commensurately%20rapid%20synaptic%20repair%20mechanisms%20on%20the%20tumor%20cell%20side%2C%20providing%20the%20first%20formidable%20barrier%20to%20CTL%20attack.%20We%20examine%20how%20breach%20of%20this%20first%20defensive%20barrier%20unleashes%20the%20inextinguishable%20%26quot%3BGreek%20fire%26quot%3B%20in%20the%20form%20of%20granzymes%20whose%20broad%20cytotoxic%20potential%20is%20linked%20to%20activation%20of%20cell%20death%20executioners%2C%20injury%20of%20vital%20organelles%2C%20and%20destruction%20of%20intracellular%20homeostasis.%20Herein%20tumor%20cells%20deploy%20slower%20but%20no%20less%20sophisticated%20defensive%20mechanisms%20in%20the%20form%20of%20enhanced%20autophagy%2C%20increased%20reparative%20capacity%2C%20and%20dysregulation%20of%20cell%20death%20pathways.%20We%20discuss%20how%20the%20newly%20discovered%20supra-molecular%20attack%20particles%20%28SMAPs%2C%20the%20%26quot%3Bscorpion%20bombs%26quot%3B%29%2C%20seek%20to%20overcome%20the%20robust%20defensive%20mechanisms%20that%20confer%20tumor%20cell%20resistance.%20Finally%2C%20we%20discuss%20the%20implications%20of%20the%20aforementioned%20attack%5C%2Fdefense%20mechanisms%20on%20the%20induction%20of%20regulated%20cell%20death%20%28RCD%29%2C%20and%20how%20different%20contemporary%20RCD%20modalities%20%28including%20apoptosis%2C%20pyroptosis%2C%20and%20ferroptosis%29%20may%20have%20profound%20implications%20for%20immunotherapy.%20Thus%2C%20we%20propose%20that%20understanding%20and%20targeting%20multiple%20steps%20of%20the%20attack%5C%2Fdefense%20process%20will%20be%20instrumental%20to%20enhance%20the%20efficacy%20of%20CTL%20anti-tumor%20activity%20and%20meet%20the%20outstanding%20challenges%20in%20clinical%20immunotherapy.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.894306%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222022-10-04T08%3A12%3A01Z%22%7D%7D%5D%7D
McKenzie, Brienne, and Salvatore Valitutti. “Resisting T Cell Attack: Tumor-Cell-Intrinsic Defense and Reparation Mechanisms.” Trends in Cancer, December 31, 2022, S2405-8033(22)00264-3. https://doi.org/10.1016/j.trecan.2022.12.003.
Puissant-Lubrano, Bénédicte, Charlène Bouthemy, Nicolas Congy-Jolivet, Jean Milhes, Vincent Minville, Nassim Kamar, Leïla Demini, Franck Zal, and Yves Renaudineau. “The Oxygen Carrier M101 Alleviates Complement Activation, Which May Be Beneficial for Donor Organ Preservation.” Frontiers in Immunology 13 (December 9, 2022): 1006761. https://doi.org/10.3389/fimmu.2022.1006761.
Cassioli, Chiara, Laura Patrussi, Salvatore Valitutti, and Cosima T. Baldari. “Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs).” International Journal of Molecular Sciences 23, no. 22 (November 17, 2022): 14255. https://doi.org/10.3390/ijms232214255.
Leveque, Edouard, Axel Rouch, Charlotte Syrykh, Julien Mazières, Laurent Brouchet, Salvatore Valitutti, Eric Espinosa, and Fanny Lafouresse. “Phenotypic and Histological Distribution Analysis Identify Mast Cell Heterogeneity in Non-Small Cell Lung Cancer.” Cancers 14, no. 6 (March 9, 2022): 1394. https://doi.org/10.3390/cancers14061394.
Filali, Liza, Marie-Pierre Puissegur, Kevin Cortacero, Sylvain Cussat-Blanc, Roxana Khazen, Nathalie Van Acker, François-Xavier Frenois, et al. “Ultrarapid Lytic Granule Release from CTLs Activates Ca2+-Dependent Synaptic Resistance Pathways in Melanoma Cells.” Science Advances 8, no. 7 (February 18, 2022): eabk3234. https://doi.org/10.1126/sciadv.abk3234.
Renaudineau, Yves, Laurent Sailler, Florence Abravanel, Jacques Izopet, Adrien Delourme, Damien Biotti, Jonathan Ciron, et al. “Glucocorticoid Use as a Cause of Non-Cellular Immune Response to SARS-Cov2 Spike in Patients with Immune System Diseases.” Journal of Autoimmunity 133 (2022): 102912. https://doi.org/10.1016/j.jaut.2022.102912.
McKenzie, Brienne, Roxana Khazen, and Salvatore Valitutti. “Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes.” Frontiers in Immunology 13 (2022): 894306. https://doi.org/10.3389/fimmu.2022.894306.
PUBLICATIONS 2021
7813506 UNNZZUAJ 2021 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22EMCUDVLJ%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Laplagne%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-28%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLaplagne%2C%20Chlo%26%23xE9%3B%2C%20Laetitia%20Ligat%2C%20Juliet%20Foote%2C%20Frederic%20Lopez%2C%20Jean-Jacques%20Fourni%26%23xE9%3B%2C%20Camille%20Laurent%2C%20Salvatore%20Valitutti%2C%20and%20Mary%20Poupot.%20%26%23x201C%3BSelf-Activation%20of%20V%26%23x3B3%3B9V%26%23x3B4%3B2%20T%20Cells%20by%20Exogenous%20Phosphoantigens%20Involves%20TCR%20and%20Butyrophilins.%26%23x201D%3B%20%26lt%3Bi%26gt%3BCellular%20%26amp%3B%20Molecular%20Immunology%26lt%3B%5C%2Fi%26gt%3B%2C%20June%2028%2C%202021.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41423-021-00720-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41423-021-00720-w%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Self-activation%20of%20V%5Cu03b39V%5Cu03b42%20T%20cells%20by%20exogenous%20phosphoantigens%20involves%20TCR%20and%20butyrophilins%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Laplagne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laetitia%22%2C%22lastName%22%3A%22Ligat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliet%22%2C%22lastName%22%3A%22Foote%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fourni%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Laurent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Poupot%22%7D%5D%2C%22abstractNote%22%3A%22The%20high%20cytotoxic%20activity%20of%20V%5Cu03b39V%5Cu03b42%20T%20lymphocytes%20against%20tumor%20cells%20makes%20them%20useful%20candidates%20in%20anticancer%20therapies.%20However%2C%20the%20molecular%20mechanism%20of%20their%20activation%20by%20phosphoantigens%20%28PAgs%29%20is%20not%20completely%20known.%20Many%20studies%20have%20depicted%20the%20mechanism%20of%20V%5Cu03b39V%5Cu03b42%20T-cell%20activation%20by%20PAg-sensed%20accessory%20cells%2C%20such%20as%20immune%20presenting%20cells%20or%20tumor%20cells.%20In%20this%20study%2C%20we%20demonstrated%20that%20pure%20resting%20V%5Cu03b39V%5Cu03b42%20T%20lymphocytes%20can%20self-activate%20through%20exogenous%20PAgs%2C%20involving%20their%20TCR%20and%20the%20butyrophilins%20BTN3A1%20and%20BTN2A1.%20This%20is%20the%20first%20time%20that%20these%20three%20molecules%2C%20concurrently%20expressed%20at%20the%20plasma%20membrane%20of%20V%5Cu03b39V%5Cu03b42%20T%20cells%2C%20have%20been%20shown%20to%20be%20involved%20together%20on%20the%20same%20and%20unique%20T%20cell%20during%20PAg%20activation.%20Moreover%2C%20the%20use%20of%20probucol%20to%20stimulate%20the%20inhibition%20of%20this%20self-activation%20prompted%20us%20to%20propose%20that%20ABCA-1%20could%20be%20implicated%20in%20the%20transfer%20of%20exogenous%20PAgs%20inside%20V%5Cu03b39V%5Cu03b42%20T%20cells%20before%20activating%20them%20through%20membrane%20clusters%20formed%20by%20%5Cu03b39TCR%2C%20BTN3A1%20and%20BTN2A1.%20The%20self-activation%20of%20V%5Cu03b39V%5Cu03b42%20T%20cells%2C%20which%20leads%20to%20self-killing%2C%20can%20therefore%20participate%20in%20the%20failure%20of%20%5Cu03b3%5Cu03b4%20T%20cell-based%20therapies%20with%20exogenous%20PAgs%20and%20should%20be%20taken%20into%20account.%22%2C%22date%22%3A%222021-06-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41423-021-00720-w%22%2C%22ISSN%22%3A%222042-0226%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-10-11T11%3A10%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22PDB9BHCK%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lafouresse%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-11%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLafouresse%2C%20Fanny%2C%20Romain%20Jugele%2C%20Sabina%20M%26%23xFC%3Bller%2C%20Marine%20Doineau%2C%20Val%26%23xE9%3Brie%20Duplan-Eche%2C%20Eric%20Espinosa%2C%20Marie-Pierre%20Puiss%26%23xE9%3Bgur%2C%20S%26%23xE9%3Bbastien%20Gadat%2C%20and%20Salvatore%20Valitutti.%20%26%23x201C%3BStochastic%20Asymmetric%20Repartition%20of%20Lytic%20Machinery%20in%20Dividing%20CD8%2B%20T%20Cells%20Generates%20Heterogeneous%20Killing%20Behavior.%26%23x201D%3B%20%26lt%3Bi%26gt%3BeLife%26lt%3B%5C%2Fi%26gt%3B%2010%20%28January%2011%2C%202021%29%3A%20e62691.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.62691%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.62691%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Stochastic%20asymmetric%20repartition%20of%20lytic%20machinery%20in%20dividing%20CD8%2B%20T%20cells%20generates%20heterogeneous%20killing%20behavior%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lafouresse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Jugele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marine%22%2C%22lastName%22%3A%22Doineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Duplan-Eche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Espinosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Pierre%22%2C%22lastName%22%3A%22Puiss%5Cu00e9gur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Gadat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22Cytotoxic%20immune%20cells%20are%20endowed%20with%20a%20high%20degree%20of%20heterogeneity%20in%20their%20lytic%20function%2C%20but%20how%20this%20heterogeneity%20is%20generated%20is%20still%20an%20open%20question.%20We%20therefore%20investigated%20if%20human%20CD8%2B%20T%20cells%20could%20segregate%20their%20lytic%20components%20during%20telophase%2C%20using%20imaging%20flow%20cytometry%2C%20confocal%20microscopy%2C%20and%20live-cell%20imaging.%20We%20show%20that%20CD107a%2B-intracellular%20vesicles%2C%20perforin%2C%20and%20granzyme%20B%20unevenly%20segregate%20in%20a%20constant%20fraction%20of%20telophasic%20cells%20during%20each%20division%20round.%20Mathematical%20modeling%20posits%20that%20unequal%20lytic%20molecule%20inheritance%20by%20daughter%20cells%20results%20from%20the%20random%20distribution%20of%20lytic%20granules%20on%20the%20two%20sides%20of%20the%20cleavage%20furrow.%20Finally%2C%20we%20establish%20that%20the%20level%20of%20lytic%20compartment%20in%20individual%20cytotoxic%20T%20lymphocyte%20%28CTL%29%20dictates%20CTL%20killing%20capacity.%22%2C%22date%22%3A%222021-01-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.62691%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222022-02-07T15%3A17%3A57Z%22%7D%7D%5D%7D
Laplagne, Chloé, Laetitia Ligat, Juliet Foote, Frederic Lopez, Jean-Jacques Fournié, Camille Laurent, Salvatore Valitutti, and Mary Poupot. “Self-Activation of Vγ9Vδ2 T Cells by Exogenous Phosphoantigens Involves TCR and Butyrophilins.” Cellular & Molecular Immunology, June 28, 2021. https://doi.org/10.1038/s41423-021-00720-w.
Lafouresse, Fanny, Romain Jugele, Sabina Müller, Marine Doineau, Valérie Duplan-Eche, Eric Espinosa, Marie-Pierre Puisségur, Sébastien Gadat, and Salvatore Valitutti. “Stochastic Asymmetric Repartition of Lytic Machinery in Dividing CD8+ T Cells Generates Heterogeneous Killing Behavior.” eLife 10 (January 11, 2021): e62691. https://doi.org/10.7554/eLife.62691.
PUBLICATIONS 2020
7813506 UNNZZUAJ 2020 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22N2G63ZLZ%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22B%5Cu00e1lint%20et%20al.%22%2C%22parsedDate%22%3A%222020-05-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BB%26%23xE1%3Blint%2C%20%26%23x161%3B.%2C%20S.%20M%26%23xFC%3Bller%2C%20R.%20Fischer%2C%20B.%20M.%20Kessler%2C%20M.%20Harkiolaki%2C%20S.%20Valitutti%2C%20and%20M.%20L.%20Dustin.%20%26%23x201C%3BSupramolecular%20Attack%20Particles%20Are%20Autonomous%20Killing%20Entities%20Released%20from%20Cytotoxic%20T%20Cells.%26%23x201D%3B%20%26lt%3Bi%26gt%3BScience%26lt%3B%5C%2Fi%26gt%3B%20368%2C%20no.%206493%20%28May%2022%2C%202020%29%3A%20897%26%23x2013%3B901.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscience.aay9207%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscience.aay9207%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Supramolecular%20attack%20particles%20are%20autonomous%20killing%20entities%20released%20from%20cytotoxic%20T%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu0161.%22%2C%22lastName%22%3A%22B%5Cu00e1lint%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20M.%22%2C%22lastName%22%3A%22Kessler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Harkiolaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Dustin%22%7D%5D%2C%22abstractNote%22%3A%22Cytotoxic%20T%20lymphocytes%20%28CTLs%29%20kill%20infected%20and%20cancerous%20cells.%20We%20detected%20transfer%20of%20cytotoxic%20multiprotein%20complexes%2C%20called%20supramolecular%20attack%20particles%20%28SMAPs%29%2C%20from%20CTLs%20to%20target%20cells.%20SMAPs%20were%20rapidly%20released%20from%20CTLs%20and%20were%20autonomously%20cytotoxic.%20Mass%20spectrometry%2C%20immunochemical%20analysis%2C%20and%20CRISPR%20editing%20identified%20a%20carboxyl-terminal%20fragment%20of%20thrombospondin-1%20as%20an%20unexpected%20SMAP%20component%20that%20contributed%20to%20target%20killing.%20Direct%20stochastic%20optical%20reconstruction%20microscopy%20resolved%20a%20cytotoxic%20core%20surrounded%20by%20a%20thrombospondin-1%20shell%20of%20~120%20nanometer%20diameter.%20Cryo-soft%20x-ray%20tomography%20analysis%20revealed%20that%20SMAPs%20had%20a%20carbon-dense%20shell%20and%20were%20stored%20in%20multicore%20granules.%20We%20propose%20that%20SMAPs%20are%20autonomous%20extracellular%20killing%20entities%20that%20deliver%20cytotoxic%20cargo%20targeted%20by%20the%20specificity%20of%20shell%20components.%22%2C%22date%22%3A%222020-05-22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.aay9207%22%2C%22ISSN%22%3A%220036-8075%2C%201095-9203%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencemag.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1126%5C%2Fscience.aay9207%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A21Z%22%7D%7D%2C%7B%22key%22%3A%222YXUQDPI%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Biolato%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBiolato%2C%20Andrea%20Michela%2C%20Liza%20Filali%2C%20Hannah%20Wurzer%2C%20C%26%23xE9%3Bline%20Hoffmann%2C%20Ernesto%20Gargiulo%2C%20Salvatore%20Valitutti%2C%20and%20Cl%26%23xE9%3Bment%20Thomas.%20%26%23x201C%3BActin%20Remodeling%20and%20Vesicular%20Trafficking%20at%20the%20Tumor%20Cell%20Side%20of%20the%20Immunological%20Synapse%20Direct%20Evasion%20from%20Cytotoxic%20Lymphocytes.%26%23x201D%3B%20In%20%26lt%3Bi%26gt%3BInternational%20Review%20of%20Cell%20and%20Molecular%20Biology%26lt%3B%5C%2Fi%26gt%3B%2C%20356%3A99%26%23x2013%3B130.%20Elsevier%2C%202020.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fbs.ircmb.2020.07.001.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Actin%20remodeling%20and%20vesicular%20trafficking%20at%20the%20tumor%20cell%20side%20of%20the%20immunological%20synapse%20direct%20evasion%20from%20cytotoxic%20lymphocytes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20Michela%22%2C%22lastName%22%3A%22Biolato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liza%22%2C%22lastName%22%3A%22Filali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%22%2C%22lastName%22%3A%22Wurzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Hoffmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Gargiulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9ment%22%2C%22lastName%22%3A%22Thomas%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22International%20Review%20of%20Cell%20and%20Molecular%20Biology%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%22978-0-12-821283-7%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1937644820300812%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A49Z%22%7D%7D%5D%7D
Bálint, š., S. Müller, R. Fischer, B. M. Kessler, M. Harkiolaki, S. Valitutti, and M. L. Dustin. “Supramolecular Attack Particles Are Autonomous Killing Entities Released from Cytotoxic T Cells.” Science 368, no. 6493 (May 22, 2020): 897–901. https://doi.org/10.1126/science.aay9207.
Biolato, Andrea Michela, Liza Filali, Hannah Wurzer, Céline Hoffmann, Ernesto Gargiulo, Salvatore Valitutti, and Clément Thomas. “Actin Remodeling and Vesicular Trafficking at the Tumor Cell Side of the Immunological Synapse Direct Evasion from Cytotoxic Lymphocytes.” In International Review of Cell and Molecular Biology, 356:99–130. Elsevier, 2020. https://doi.org/10.1016/bs.ircmb.2020.07.001.
PUBLICATIONS 2019
7813506 UNNZZUAJ 2019 1 chicago-fullnote-bibliography 50 date desc 34882 https://www.crct-inserm.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2233KF7QUH%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khazen%20et%20al.%22%2C%22parsedDate%22%3A%222019-08-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKhazen%2C%20Roxana%2C%20Sabina%20M%26%23xFC%3Bller%2C%20Fanny%20Lafouresse%2C%20Salvatore%20Valitutti%2C%20and%20Sylvain%20Cussat-Blanc.%20%26%23x201C%3BSequential%20Adjustment%20of%20Cytotoxic%20T%20Lymphocyte%20Densities%20Improves%20Efficacy%20in%20Controlling%20Tumor%20Growth.%26%23x201D%3B%20%26lt%3Bi%26gt%3BScientific%20Reports%26lt%3B%5C%2Fi%26gt%3B%209%2C%20no.%201%20%28August%2023%2C%202019%29%3A%2012308.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-019-48711-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-019-48711-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sequential%20adjustment%20of%20cytotoxic%20T%20lymphocyte%20densities%20improves%20efficacy%20in%20controlling%20tumor%20growth%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lafouresse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Cussat-Blanc%22%7D%5D%2C%22abstractNote%22%3A%22Understanding%20the%20human%20cytotoxic%20T%20lymphocyte%20%28CTL%29%20biology%20is%20crucial%20to%20develop%20novel%20strategies%20aiming%20at%20maximizing%20their%20lytic%20capacity%20against%20cancer%20cells.%20Here%20we%20introduce%20an%20agent-based%20model%2C%20calibrated%20on%20population-scale%20experimental%20data%20that%20allows%20quantifying%20human%20CTL%20per%20capita%20killing.%20Our%20model%20highlights%20higher%20individual%20CTL%20killing%20capacity%20at%20lower%20CTL%20densities%20and%20fits%20experimental%20data%20of%20human%20melanoma%20cell%20killing.%20The%20model%20allows%20extending%20the%20analysis%20over%20prolonged%20time%20frames%2C%20difficult%20to%20investigate%20experimentally%2C%20and%20reveals%20that%20initial%20high%20CTL%20densities%20hamper%20efficacy%20to%20control%20melanoma%20growth.%20Computational%20analysis%20forecasts%20that%20sequential%20addition%20of%20fresh%20CTL%20cohorts%20improves%20tumor%20growth%20control.%20In%20vivo%20experimental%20data%2C%20obtained%20in%20a%20mouse%20melanoma%20model%2C%20confirm%20this%20prediction.%20Taken%20together%2C%20our%20results%20unveil%20the%20impact%20that%20sequential%20adjustment%20of%20cellular%20densities%20has%20on%20enhancing%20CTL%20efficacy%20over%20long-term%20confrontation%20with%20tumor%20cells.%20In%20perspective%2C%20they%20can%20be%20instrumental%20to%20refine%20CTL-based%20therapeutic%20strategies%20aiming%20at%20controlling%20tumor%20growth.%22%2C%22date%22%3A%22Aug%2023%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-019-48711-2%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A32Z%22%7D%7D%2C%7B%22key%22%3A%226D3M74DE%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cordella%20et%20al.%22%2C%22parsedDate%22%3A%222019-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCordella%2C%20Martina%2C%20Claudio%20Tabolacci%2C%20Cinzia%20Senatore%2C%20Stefania%20Rossi%2C%20Sabina%20Mueller%2C%20Carla%20Lintas%2C%20Adriana%20Eramo%2C%20et%20al.%20%26%23x201C%3BTheophylline%20Induces%20Differentiation%20and%20Modulates%20Cytoskeleton%20Dynamics%20and%20Cytokines%20Secretion%20in%20Human%20Melanoma-Initiating%20Cells.%26%23x201D%3B%20%26lt%3Bi%26gt%3BLife%20Sciences%26lt%3B%5C%2Fi%26gt%3B%20230%20%28August%201%2C%202019%29%3A%20121%26%23x2013%3B31.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lfs.2019.05.050%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lfs.2019.05.050%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Theophylline%20induces%20differentiation%20and%20modulates%20cytoskeleton%20dynamics%20and%20cytokines%20secretion%20in%20human%20melanoma-initiating%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Cordella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%22%2C%22lastName%22%3A%22Tabolacci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cinzia%22%2C%22lastName%22%3A%22Senatore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Rossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22Mueller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carla%22%2C%22lastName%22%3A%22Lintas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%22%2C%22lastName%22%3A%22Eramo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22D%27Arcangelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Facchiano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Facchiano%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20Cutaneous%20melanoma%20is%20the%20most%20aggressive%20skin%20cancer%2C%20derived%20from%20neoplastic%20transformation%20of%20melanocytes.%20Since%20several%20evidences%20highlighted%20the%20importance%20of%20a%20hierarchical%20model%20of%20differentiation%20among%20cancer%20cells%2C%20closely%20related%20to%20resistance%20mechanisms%20and%20tumor%20relapse%2C%20we%20investigated%20the%20effects%20of%20theophylline%20%28Theo%29%2C%20a%20methylxanthine%20commonly%20used%20in%20treatment%20of%20respiratory%20diseases%2C%20on%20melanoma%20cells%20with%20different%20degree%20of%20differentiation%2C%20including%20patient-derived%20melanoma-initiating%20cells.%5CnMATERIALS%20AND%20METHODS%3A%20The%20antiproliferative%20and%20antimetastatic%20effects%20of%20Theo%20was%20demonstrated%20by%20cell%20counting%2C%20adhesion%20and%20migration%20assays%20on%20A375%20and%20SK-MEL-30%20cells.%20Further%2C%20Theo%20ability%20to%20reduce%20cell%20growth%20was%20highly%20significant%20in%20A375-derived%20spheroids%20and%20in%20two%20patient-derived%20melanoma-initiating%20cells%20%28MICs%29.%20In%20order%20to%20identify%20pathways%20potentially%20involved%20in%20the%20antineoplastic%20properties%20of%20Theo%2C%20a%20comparative%20mass%20spectrometry%20proteomic%20analysis%20was%20used.%20Then%2C%20melanin%20content%2C%20tyrosinase%20and%20tissue%20transglutaminase%20activities%20as%20differentiation%20markers%20and%20actin%20re-organization%20through%20confocal%20microscopy%20were%20evaluated.%20Furthermore%2C%20a%20secretome%20profile%20of%20MICs%20after%20Theo%20treatments%20was%20performed%20by%20multiplex%20immunoassay.%5CnKEY%20FINDINGS%3A%20Obtained%20results%20demonstrate%20inhibitory%20effects%20of%20Theo%20on%20melanoma%20cell%20proliferation%20and%20migration%2C%20mainly%20in%20MICs%2C%20together%20with%20the%20induction%20of%20differentiation%20parameters.%20Moreover%2C%20our%20data%20indicate%20that%20the%20known%20anti-melanoma%20effect%20of%20Theo%20is%20due%20also%20to%20its%20ability%20to%20interfere%20with%20cytoskeleton%20dynamics%20and%20to%20induce%20the%20secretion%20of%20inflammatory%20molecules%20involved%20in%20recruitment%20of%20immunosuppressive%20cells%20in%20tumor%20microenvironment.%5CnSIGNIFICANCE%3A%20Data%20strongly%20suggest%20that%20Theo%20supplement%2C%20either%20as%20drug%20or%20as%20dietary%20supply%2C%20may%20represent%20a%20potent%20additional%20weapon%20against%20melanoma.%22%2C%22date%22%3A%22Aug%2001%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lfs.2019.05.050%22%2C%22ISSN%22%3A%221879-0631%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22UECBRZMH%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gonnord%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGonnord%2C%20Pauline%2C%20Manon%20Costa%2C%20Arnaud%20Abreu%2C%20Michael%20Peres%2C%20Lo%26%23xEF%3Bc%20Ysebaert%2C%20S%26%23xE9%3Bbastien%20Gadat%2C%20and%20Salvatore%20Valitutti.%20%26%23x201C%3BMultiparametric%20Analysis%20of%20CD8%2B%20T%20Cell%20Compartment%20Phenotype%20in%20Chronic%20Lymphocytic%20Leukemia%20Reveals%20a%20Signature%20Associated%20with%20Progression%20toward%20Therapy.%26%23x201D%3B%20%26lt%3Bi%26gt%3BOncoimmunology%26lt%3B%5C%2Fi%26gt%3B%208%2C%20no.%204%20%282019%29%3A%20e1570774.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2019.1570774%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2019.1570774%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiparametric%20analysis%20of%20CD8%2B%20T%20cell%20compartment%20phenotype%20in%20chronic%20lymphocytic%20leukemia%20reveals%20a%20signature%20associated%20with%20progression%20toward%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauline%22%2C%22lastName%22%3A%22Gonnord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Abreu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Peres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lo%5Cu00efc%22%2C%22lastName%22%3A%22Ysebaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Gadat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22CD8%2B%20T%20cells%20are%20frontline%20defenders%20against%20cancer%20and%20primary%20targets%20of%20current%20immunotherapies.%20In%20CLL%2C%20specific%20functional%20alterations%20have%20been%20described%20in%20circulating%20CD8%2B%20T%20cells%2C%20yet%20a%20global%20view%20of%20the%20CD8%2B%20T%20cell%20compartment%20phenotype%20and%20of%20its%20real%20impact%20on%20disease%20progression%20is%20presently%20elusive.%20We%20developed%20a%20multidimensional%20statistical%20analysis%20of%20CD8%2B%20T%20cell%20phenotypic%20marker%20expression%20based%20on%20whole%20blood%20multi-color%20flow-cytometry.%20The%20analysis%20comprises%20both%20unsupervised%20statistics%20%28hClust%20and%20PCA%29%20and%20supervised%20classification%20methods%20%28Random%20forest%2C%20Adaboost%20algorithm%2C%20Decision%20tree%20learning%20and%20logistic%20regression%29%20and%20allows%20to%20cluster%20patients%20by%20comparing%20multiple%20phenotypic%20markers%20expressed%20by%20CD8%2B%20T%20cells.%20Our%20results%20reveal%20a%20global%20CD8%2B%20T%20cell%20phenotypic%20signature%20in%20CLL%20patients%20that%20is%20significantly%20modified%20when%20compared%20to%20healthy%20donors.%20We%20also%20uncover%20a%20CD8%2B%20T%20cell%20signature%20characteristic%20of%20patients%20evolving%20toward%20therapy%20within%206%5Cu00a0months%20after%20phenotyping.%20The%20unbiased%2C%20not%20predetermined%20and%20multimodal%20approach%20highlights%20a%20prominent%20role%20of%20the%20memory%20compartment%20in%20the%20prognostic%20signature.%20The%20analysis%20also%20reveals%20that%20imbalance%20of%20the%20central%5C%2Feffector%20memory%20compartment%20in%20CD8%2B%20T%20cells%20can%20occur%20irrespectively%20of%20the%20elapsed%20time%20after%20diagnosis.%20Taken%20together%20our%20results%20indicate%20that%2C%20in%20CLL%20patients%2C%20CD8%2B%20T%20cell%20phenotype%20is%20imprinted%20by%20disease%20clinical%20progression%20and%20reveal%20that%20CD8%2B%20T%20cell%20memory%20compartment%20alteration%20is%20not%20only%20a%20hallmark%20of%20CLL%20disease%20but%20also%20a%20signature%20of%20disease%20evolution%20toward%20the%20need%20for%20therapy.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F2162402X.2019.1570774%22%2C%22ISSN%22%3A%222162-4011%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A09Z%22%7D%7D%5D%7D
Khazen, Roxana, Sabina Müller, Fanny Lafouresse, Salvatore Valitutti, and Sylvain Cussat-Blanc. “Sequential Adjustment of Cytotoxic T Lymphocyte Densities Improves Efficacy in Controlling Tumor Growth.” Scientific Reports 9, no. 1 (August 23, 2019): 12308. https://doi.org/10.1038/s41598-019-48711-2.
Cordella, Martina, Claudio Tabolacci, Cinzia Senatore, Stefania Rossi, Sabina Mueller, Carla Lintas, Adriana Eramo, et al. “Theophylline Induces Differentiation and Modulates Cytoskeleton Dynamics and Cytokines Secretion in Human Melanoma-Initiating Cells.” Life Sciences 230 (August 1, 2019): 121–31. https://doi.org/10.1016/j.lfs.2019.05.050.
Gonnord, Pauline, Manon Costa, Arnaud Abreu, Michael Peres, Loïc Ysebaert, Sébastien Gadat, and Salvatore Valitutti. “Multiparametric Analysis of CD8+ T Cell Compartment Phenotype in Chronic Lymphocytic Leukemia Reveals a Signature Associated with Progression toward Therapy.” Oncoimmunology 8, no. 4 (2019): e1570774. https://doi.org/10.1080/2162402X.2019.1570774.

LES MEMBRES DE L’ÉQUIPE

Lucas Nunez
Doctorant / PhD student
Alejandro Vanazzi
Ingénieur de laboratoire / laboratory engineer
Aurélie Montagne
Chercheur Post-Doctorant / Post-Doc researcher
Agathe Bernand
Ingénieur de laboratoire / laboratory engineer
Amandine Michelet
Doctorant / PhD student
Roxana Khazen
Chercheur Post-Doctorant / Post-Doc researcher
Salvatore Valitutti
Chercheur statutaire / permanent scientist
Chloé Lamesa
Clinicien Chercheur / Researcher hospital practitioner
Sabina Mueller
Ingénieur de laboratoire / laboratory engineer
Marie-Pierre Puisségur
Ingénieur de laboratoire / laboratory engineer
Lucie Demeersseman
Ingénieur de laboratoire / laboratory engineer
Frecia Rodriguez
Chercheur invité / visiting researcher
Fanny Lafouresse
Chercheur statutaire / permanent scientist

LES PARTENAIRES & FINANCIERS

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches contre le Cancer de Toulouse (Oncopole)

Toulouse - FR

Suivez nous sur les réseaux sociaux

Nous contacter

+33 5 82 74 15 75

Nous rejoindre ?

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches en Cancérologie de Toulouse (Oncopole)

Toulouse – FR

Nous contacter

05 82 74 15 75

Envie de rejoindre
L’équipe du CRCT ?

Pin It on Pinterest

Centre de Recherches en Cancérologie de Toulouse
Préambule

Afin d’améliorer votre expérience de navigation. Les cookies fournissent des informations sur la façon dont le site est utilisé: statistiques telles que le nombre de visiteurs, la durée moyenne des visites ou encore le nombre de pages vues. Par ailleurs, la désactivation des cookies risque de vous empêcher d’utiliser certaines fonctionnalités, notamment le partage d’un contenu via les réseaux sociaux.
En cliquant sur "Accepter", vous acceptez l'utilisation de cookies en provenance de ce site ainsi que notre politique de confidentialité.

Vous pouvez ajuster tous vos paramètres de cookies en naviguant dans les onglets à gauche.